Recently, breast implants have been associated with an increased chance of developing a rare form of lymphoma.
This particular form of lymphoma is referred to as “breast implant-associated anaplastic large cell lymphoma” (BIA-ALCL).
Those with textured implants, as opposed to smooth implants, are at an even higher risk of developing this form of cancer.
At the present time, the FDA has received over 359 medical device reports of BIA-ALCL, nine of which include deaths. Furthermore, 203 of these cases involved textured implants, and only 28 involved smooth implants.
Unfortunately, diagnoses in the reported cases has “only been identified in patients with late onset of symptoms such as pain, lumps, swelling, or asymmetry.” This implies that early diagnosis of BIA-ALCL may not be a possibility.
We are interested in cases concerning BIA-ALCL, and urge you to complete a free case evaluation form if you or someone you know has been diagnosed with lymphoma after having breast implants.
- Breast Implants: Lymphoma / Blood Cancer Cases Overview
- Breast Implants and Lymphoma: The Disease
- Breast Implants and Lymphoma: FDA Information
- Breast Implants and Lymphoma: Resources
- Breast Implants and Lymphoma: Frequently Asked Questions